Novartis Ups Forecast on Lack of Diovan Competitor

July 17 (Bloomberg) -- Novartis AG raised its full-year forecast as generic competition for the Diovan blood-pressure drug failed to materialize in the U.S. Sam Fazeli reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Luxury Brand Zegna Sees 'Gradual Rebound' in 2016
16:32 - Ermenegildo Zegna, chief executive officer of the Italian luxury-suit maker that bears his name, talks about the prospects for business globally and in China. He speaks with Bloomberg Television's Angie Lau. (Source: Bloomberg)
  • Is a Bubble Forming in China's Bond Market?
  • Germany, U.S. Losing Patience With VW: Siebert
  • How Much Trouble Does VW Face in the U.S.?